Passage Bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-102.06	-136.13	-185.39	-112.23	-45.63	-12.77
Depreciation & Amortization	3.72	3.68	1.54	0.8	0.13	0
Share-Based Compensation	10.92	18.95	32.69	14.58	1.45	0
Other Operating Activities	9.16	-4.72	24.27	16.33	4.15	-5.8
Operating Cash Flow	-78.26	-118.21	-126.88	-80.52	-39.9	-18.57
Capital Expenditures	-0.15	-5.27	-25.64	-1.65	-1.19	-0.03
Change in Investments	65.38	30.47	-20.17	-170.46	0	0
Other Investing Activities	-	-	-	-	-0.5	-2.52
Investing Cash Flow	65.24	25.2	-45.81	-172.11	-1.69	-2.54
Share Issuance / Repurchase	0.14	0.43	166.99	228.75	0.18	0
Debt Issued / Paid	0	-1.79	0	0	0	0
Other Financing Activities	-	-	-0.34	-	175.43	45.97
Financing Cash Flow	0.14	-1.35	166.66	228.75	175.6	45.97
Net Cash Flow	-12.89	-94.36	-6.04	-23.87	134.01	24.86
Free Cash Flow	-78.41	-123.48	-152.52	-82.17	-41.09	-18.6
Free Cash Flow Per Share	-1.43	-2.27	-2.86	-2.13	-9.70	-5.17

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).